Salmanov Aidyn G, Suslikova Lidiya V, Pandei Svitlana A, Rud Victor O, Kokhanov Igor V, Butska Victoria Ye, Tymchenko Alexander G
SHUPYK NATIONAL HEALTHCARE UNIVERSITY OF UKRAINE, KYIV, UKRAINE.
NATIONAL PIROGOV MEMORIAL MEDICAL UNIVERSITY, VINNYTSIA, UKRAINE.
Wiad Lek. 2021;74(3 cz 1):406-412.
The aim: To obtain the first estimates of the current prevalence of healthcare-associated deep pelvic tissue infection and other infections of the female reproductive tract (vagina, ovaries, uterus) including chorioamnionitis, and antimicrobial resistance of causing pathogens in Ukraine.
Materials and methods: We performed a retrospective multicenter cohort study was based on surveillance data. The study population included 3,053 women's who underwent gynecological surgery or other procedures from 2017 to 2019 in 7 women hospitals in Ukraine. Definitions of healthcare-associated reproductive tract infection were used from the CDC/ NHSN.
Results: The prevalence of healthcare-associated deep pelvic tissue infection and other infections of the female reproductive tract was 26.3%. Incidence of infection was: 13.3% Pelvic abscess or cellulitis, 14.6% Adnexa utery, 9.5% Salpingitis, 7.1% Oophoritis, 12.2% Parametritis, 4.6% Chorioamnionitis, and 38.8% Bacterial Vaginitis. The predominant pathogens were: Escherichia coli (25.6%), Enterobacter spp. (11.4%), Klebsiella pneumoniae (10.6%), Staphylococcus aureus (8.5%), Enterococcus faecalis (7.2%) and Pseudomonas aeruginosa (7.1%). Methicillin-resistance was observed in 14.3% of S. aureus (MRSA). The overall proportion of extended spectrum beta-lactamases (ESBL) production among Enterobacteriaceae was 20.8%. The prevalence of ESBL production among E. coli isolates was 24.7% and among K. pneumoniae 11.9%. Resistance to thirdgeneration cephalosporins was observed in 12.8% E.coli and 9.2% K. pneumoniae isolates. Carbapenem resistance was identified in 8.5% of P.aeruginosa isolates.
Conclusions: Healthcare associated deep pelvic tissue infection and other infections of the female reproductive tract in Ukraine is a common occurrence and many cases are caused by pathogens that are resistant to antibiotics.
旨在初步估算乌克兰目前医疗保健相关的深部盆腔组织感染以及包括绒毛膜羊膜炎在内的女性生殖道(阴道、卵巢、子宫)其他感染的患病率,以及致病病原体的抗菌耐药性。
材料与方法:我们基于监测数据进行了一项回顾性多中心队列研究。研究人群包括2017年至2019年在乌克兰7家妇科医院接受妇科手术或其他治疗的3053名女性。采用美国疾病控制与预防中心/美国国家医疗安全网络(CDC/NHSN)对医疗保健相关生殖道感染的定义。
医疗保健相关的深部盆腔组织感染以及女性生殖道其他感染的患病率为26.3%。感染发生率分别为:盆腔脓肿或蜂窝织炎13.3%,附件炎14.6%,输卵管炎9.5%,卵巢炎7.1%,子宫旁组织炎12.2%,绒毛膜羊膜炎4.6%,细菌性阴道炎38.8%。主要病原体为:大肠埃希菌(25.6%)、肠杆菌属(11.4%)、肺炎克雷伯菌(10.6%)、金黄色葡萄球菌(8.5%)、粪肠球菌(7.2%)和铜绿假单胞菌(7.1%)。14.3%的金黄色葡萄球菌(MRSA)对甲氧西林耐药。肠杆菌科细菌中产超广谱β-内酰胺酶(ESBL)的总体比例为20.8%。大肠埃希菌分离株中产ESBL的比例为24.7%,肺炎克雷伯菌为11.9%。12.8%的大肠埃希菌分离株和9.2%的肺炎克雷伯菌分离株对第三代头孢菌素耐药。8.5%的铜绿假单胞菌分离株对碳青霉烯类耐药。
乌克兰医疗保健相关的深部盆腔组织感染以及女性生殖道其他感染很常见,许多病例由对抗生素耐药的病原体引起。